• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Nathaniel Yeager

Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael Babich, others, in pre-trial mode.

Steve Walker    July 7, 2017 September 6, 2017    No Comments on Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael Babich, others, in pre-trial mode.

The News: A former employee of Insys Therapeutics Inc. (Chandler AZ) pleaded guilty last week to having conspired to defraud insurers into paying for an expensive fentanyl-based drug that is… Read more »

Corporate, Government    Alec Burlakoff, Charles Cooper, Elizabeth Gurrieri, Fentanyl, Insys Therapeutics Inc., Jeff Sessions, Jefferies, Jennifer C. Boal, Joseph Rowan, Michael Gurry, Michael L. Babich, Nathaniel Yeager, Patrick Burns, RBC Capital Markets, Reuters, Richard Simon, Rx Hall of Shame, Subsys, Sunrise Lee, Taxpayers Against Fraud Education Fund, The New York Times

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
  • IPOs are back in business; well, unless and until there’s another government shutdown.
  • And now for something completely different in biotech: Lab-grown, “clean” meat. If Bill Gates and Warren Buffett like the idea...well?...
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress